My guest today is from Infuserve  America, a 503A that has a division that focuses on investigational drugs, otherwise known as clinical trials. I was first introduced to this idea by some associates at a pharmaceutical company, they told me how they struggled to find 503A's to work with due to a variety of reasons. Some are because of misconceptions on the regulatory issues. Some are due to perceived GMP standards that they think a 503 a couldn't possibly attain. So I was really looking forward to this conversation. They've been working in this space for years and was able to shed light on how they got into this area, and what it's been like working on clinical trials with a variety of organizations.

Support the show